NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,820.00+₹59.00 (+3.35%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.82% below the high.
Loading market information…
NSE · PANACEABIO.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:54 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Panacea Biotec Limited’s quoted price sits in the lower half of its reported 52-week range, 51.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Panacea Biotec Limited’s forward annual dividend is ₹0.75 per share, paid annual. The forward yield is 0.24% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Panacea Biotec Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1984 and headquartered in New Delhi, India, Panacea Biotec Limited is a biotechnology company dedicated to the innovation, production, and commercialization of pharmaceuticals, vaccines, and biosimilars. Its primary market is India, with operations segmented into Vaccines and Formulations. The company's pharmaceutical offerings comprise proprietary medicines targeting diverse medical fields such as pain management, diabetes, cardiovascular health, oncology, renal disease, osteoporosis, anti-tubercular therapy, and gastro-intestinal care. In addition to these, Panacea Biotec develops and distributes vaccines for conditions like anthrax, dengue, and Japanese encephalitis, among others. The firm maintains a robust global presence, exporting its goods to over 30 countries, including key markets such as the United States, Germany, the Russian Federation, Sri Lanka, and the Philippines. Notably, Panacea Biotec has established significant strategic alliances, including a partnership with the Russian Direct Investment Fund for the manufacture of the Sputnik-V COVID-19 vaccine. It also collaborates with the Coalition for Epidemic Preparedness Innovations (CEPI) and the Translational Health Science and Technology Institute (THSTI) to pioneer vaccine candidates designed to combat SARS-CoV-2 variants and other beta coronaviruses.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,820.00+₹59.00 (+3.35%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.82% below the high.
₹9,842.00+₹178.00 (+1.84%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹178.77-₹6.16 (-3.33%)
IOL Chemicals and Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 19.92% below the high.
₹636.35-₹18.90 (-2.88%)
Solara Active Pharma Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 17.78% below the high.
₹87.82-₹1.49 (-1.67%)
Alembic Limited’s quoted price sits in the lower half of its reported 52-week range, 25.4% below the high.
₹205.70-₹3.80 (-1.81%)
Indoco Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 28.58% below the high.
₹504.85+₹6.90 (+1.39%)
Krsnaa Diagnostics Limited’s quoted price sits in the lower half of its reported 52-week range, 39.76% below the high.
